Literature DB >> 10560902

Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders.

A Oshima1, T Higuchi, Y Fujiwara, M Iida, A Iwanami, S Kanba, N Motohashi, Y Uchitomi, K Yamada, S Yamawaki.   

Abstract

The answers to a questionnaire on the practical prescription in mood disorders from 298 Japanese psychiatrists was obtained. As the first-line treatment, a majority of respondents chose newer tricyclic agents (TCA) or non-TCA for moderate depression and older TCA for severe depression both with and without psychotic features. Combination therapy with antidepressants and anxiolytics was fairly popular in moderate depression, while antidepressant/neuroleptic combination was more common in severe psychotic depression. Sulpiride was the most favored drug for dysthymia. Although lithium was the most popular for bipolar mania, respondents were divided on the treatment of bipolar depression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560902

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

Review 1.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

2.  Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

Authors:  Konstantinos N Fountoulakis; Xenia Gonda; Eduard Vieta; Zoltan Rihmer
Journal:  Ann Gen Psychiatry       Date:  2011-03-24       Impact factor: 3.455

3.  Evaluation of the Total Design Method in a survey of Japanese dentists.

Authors:  Yukie Nakai; Peter Milgrom; Toshiko Yoshida; Chikako Ishihara; Tsutomu Shimono
Journal:  BMC Med Res Methodol       Date:  2005-08-23       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.